Hi-Crush Partners LP
HCLP
Delayed Nyse - 09/22 10:02:02 pm
10.1USD
+3.06%

Helped by a technical support level

Envoyer par e-mail
David Meurisse
Contributor / Partner

Strategy published on : 07/13/2017 | 17:26

long trade
Stop-loss triggered

Entry price : 9.5$
Target : 10.95$
Stop-loss : 8.85$
Potential : 15.26%

Hi-Crush Partners LP shares are closing back in on major support levels around 9.2 USD based on daily price data, which could offer attractive entry points.
Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

● In a short-term perspective, the company has interesting fundamentals.


Strengths

● The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 9.2 USD in weekly data.

● Graphically speaking, the timing seems perfect for purchasing the stock close to the USD 9.2 support.

● According to sales estimates from analysts polled by Thomson-Reuters, the company is among the best with regard to growth.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Historically, the company has been releasing figures that are above expectations.

● Its low valuation, with P/E ratio at 8.39 and 3.8 for the ongoing fiscal year and 2018 respectively, makes the stock pretty attractive with regard to earnings multiples.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.

● For the past twelve months, EPS forecast has been revised upwards.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.


Weaknesses

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● Below the resistance at 15.1 USD, the stock shows a negative configuration when looking looking at the weekly chart.

Zonebourse.com 2017
Envoyer par e-mail